NCT06524037 Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms
| NCT ID | NCT06524037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Chongqing Medical University |
| Condition | Metabolic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2032-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-01-01 with a primary completion date of 2032-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Metabolic disorders are involved in the occurrence and development of a variety of chronic diseases and tumors. There are many common risk factors between chronic diseases and tumors. However, the mechanisms of chronic diseases and tumors caused by metabolic disorders are not completely clear. By observing the relationship between metabolic indexes and chronic diseases and tumors, the investigators intend to explore the possible mechanisms of metabolic status participating in the occurrence and development of chronic diseases and tumors.
Eligibility Criteria
Inclusion Criteria: * adult aged ≥18 years old * Completed health screening Exclusion Criteria: * aged \<18 years old * pregnancy
Contact & Investigator
Qin Duan, doctor
STUDY DIRECTOR
The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Frequently Asked Questions
Who can join the NCT06524037 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Metabolic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06524037 currently recruiting?
Yes, NCT06524037 is actively recruiting participants. Contact the research team at 570549500@qq.com for enrollment information.
Where is the NCT06524037 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT06524037 clinical trial?
NCT06524037 is sponsored by First Affiliated Hospital of Chongqing Medical University. The principal investigator is Qin Duan, doctor at The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.. The trial plans to enroll 2,000 participants.